NIH-funded research NIH-funded research

Developing new methods for early cancer detection

Official title: NCE FOR COMMERCIALIZATION CENTER TASK ORDER FOR CANCER SCREENING RESEARCH NETWORK

Funded at Venturewell · NIH-11167410 · Data updated 2026-11-12

This study is working on new ways to test for cancer that could help catch it earlier, making it easier for patients to get accurate and accessible screenings that lead to better treatment options.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVenturewell
NIH-funded
Lab location1 site (Hadley, United States)
Project startFebruary 6, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$528,678
NIH project number75N92022D00013-P00005-759202300001-1
Project IDNIH-11167410 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for cancer or those who may benefit from enhanced screening techniques.

Less likely to help

Patients who are not at risk for cancer or who have already been diagnosed may not receive direct benefits from this research.

What this research studies

This research focuses on creating and evaluating innovative assays for cancer screening, aiming to improve early detection methods. By establishing a comprehensive evaluation strategy, the project seeks to enhance the accuracy and effectiveness of cancer screening tests. Patients may benefit from more reliable and accessible screening options that could lead to earlier diagnosis and treatment. The research involves collaboration with various stakeholders in the cancer screening field to ensure practical application of the findings.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer screening methods, improving early detection rates and patient outcomes.

How similar studies have gone: Previous research has shown promise in developing new screening assays, indicating that this approach could lead to significant advancements in cancer detection.

Where this research is happening

  • Venturewell
    Hadley, United States
    Active

Researchers

  • Principal investigator: Marino, Mark — Venturewell
  • Study coordinator: Marino, Mark

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.